USP is planning to extend its effort to help Africa better assure the quality and integrity of its pharmaceutical supply with a new USP training/laboratory center slated to be located in Ghana.
Providing context for the USP effort is an early-April FDA-commissioned report by the Institute of Medicine (IOM) that highlights weaknesses in the regulatory processes of countries in the sub-Saharan Africa region and points to how shortages of laboratory infrastructure encourage other gaps in regulatory systems and supply chain controls.
The new USP Sub-Saharan Africa Center for Pharmaceutical Advancement and Training (CePAT) will serve the region with an integrated platform for training, education, consulting and laboratory capabilities, and will offer a systematic approach to the quality control of medicines.
[CLICK HERE for the complete story. Nonsubscribers can purchase the story for $195 by contacting Jonathan Trethowan (Jonathan@ipq.org). For subscription/license information, click here.]
